News & Articles
Selected Filters:
Identification of Schizophrenia Risk Factors Using Advanced Genetic Analyses at Harvard Medical School
Learn how researchers used ddPCR to functionally characterize a chromosomal locus with confirmed schizophrenia associated risk
New Method to Assess Effectiveness of Genome-Editing Technologies
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
CRISPR gRNA Lentivector Cloning Kits
Breaking New Ground in Transcriptomics: Resolve Full-Length Transcripts for Unprecedented Insights into Novel Isoforms and Disease-Causing Splicing Variants
GATC Biotech’s INVIEW TRANSCRIPTOME ISOFORM DISCOVER establishes a new quality standard for all isoform-related research
Thermo Fisher Scientific Announces Next-Generation Sequencing Assay for Liquid Biopsy Research
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors
Increased Efficiency and Faster Viral Load Results with DxN VERIS Molecular Diagnostics System
Niguarda Hospital, Milan, shares experiences in newly available case study
QIAGEN Joins Consortium to Map Microbial Genomes in 54 Cities
Project that measured pathogens in New York City subways goes global this summer
QIAGEN Launches QIAsure Methylation Test to Determine Cervical Cancer Risk
New follow-up assay helps stratify patients with transforming HPV infections
GATCLIQUID ONCOTARGET Expanded to Cover Blood Cancers such as Acute Myeloid Leukemia
Liquid biopsy test from GATC Biotech offers non-invasive analysis of 12 actionable genomic alterations in circulating cell-free DNA
NIGHTSEA Shifts Fluorescence Stereomicroscopy Paradigm
NIGHTSEA proudly announces the1000th installation of its Model SFA Stereomicroscope Fluorescence Adapter
QIAGEN forms Lung Cancer Expert Alliance
Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS
QIAGEN Launches Liquid Biopsy Workflow for GeneReader NGS System
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples
Horizon Discovery Group’s Molecular Reference Standards Integrated into QIAGEN GeneReader NGS System
Future joint collaborations are expected as work continues to unlock the full clinical and research potential of both technologies
QIAGEN Integrates Quality Control Tools into GeneReader NGS System
Reference data set from Horizon affirms proven accuracy of GeneReader workflow
Peer Review Research Demonstrates Benefits of Chromatrap Solid State ChIP Technology
Studies demonstrate pioneering research possible using ChIP technology
Horizon and Ubiquigent Enter into Collaboration Agreement
Horizon’s X-MAN cell lines to be made available in conjunction with Ubiquigent’s ubiquitin-related Drug Discovery Services
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting
Rapid Production of Ultra-Pure DNA
Chromatrap® has announced a new 96-well high throughput purification plate for production of ultra-pure DNA